wiki pageCreated: 2026-04-02T07:19:17By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-genes-psma2
📖 Wiki Page
gene658 wordssynced 2026-04-02
PSMA2 Gene
Introduction
Psma2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PSMA2 (Proteasome Subunit Alpha 2) encodes the α2 subunit of the 20S proteasome core particle. PSMA2 is a structural component of the outer alpha ring of the 20S proteasome, where it plays a critical role in controlling substrate entry into the proteolytic chamber<sup>[1]</sup>. The proteasome is the primary cellular machinery for targeted protein degradation, essential for maintaining proteostasis in all eukaryotic cells, including [neurons](/entities/neurons).
Structure
The PSMA2 protein adopts a classic α-helical fold characteristic of proteasome α subunits:
...
PSMA2 Gene
Introduction
Psma2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PSMA2 (Proteasome Subunit Alpha 2) encodes the α2 subunit of the 20S proteasome core particle. PSMA2 is a structural component of the outer alpha ring of the 20S proteasome, where it plays a critical role in controlling substrate entry into the proteolytic chamber<sup>[1]</sup>. The proteasome is the primary cellular machinery for targeted protein degradation, essential for maintaining proteostasis in all eukaryotic cells, including [neurons](/entities/neurons).
Structure
The PSMA2 protein adopts a classic α-helical fold characteristic of proteasome α subunits:
N-terminal domain: Forms the substrate entry portal; contains the HbYX motif critical for 19S regulatory particle binding
Core domain: Seven α-helices arranged in a barrel-like structure
Binding interface: Forms contacts with adjacent α subunits (PSMA1, PSMA5, PSMA7) in the alpha ring
The 20S proteasome comprises four heptameric rings: two outer α-rings (containing PSMA1-7) and two inner β-rings (containing PSMB1-7)<sup>[2]</sup>.
Normal Function
Proteasome Assembly and Structure
PSMA2 is an essential component of the 20S proteasome:
Co-assembles with PSMA1, PSMA3-7 to form the outer α-ring
The α-ring controls substrate access through the gated channel
N-terminal residues (Thr1, Asp9, Lys66) form the gate that regulates entry
Cellular Functions
Protein degradation: The proteasome degrades ubiquitin-tagged proteins via the proteolytic β subunits (PSMB1-7)
Quality control: Removes misfolded, damaged, and oxidized proteins
Regulatory protein turnover: Controls levels of transcription factors, cell cycle proteins, and signaling molecules
Stress response: Degrades stress-damaged proteins during cellular stress
Neuronal Functions
Synaptic protein turnover: Rapid degradation of synaptic proteins for plasticity
Neuroprotection: Clearance of toxic protein aggregates
Axonal maintenance: Proteostasis in long axons
Role in Neurodegeneration
Alzheimer's Disease
PSMA2 and the proteasome system are affected in AD<sup>[3]</sup>:
Proteasome activity is reduced in AD brain
Impaired degradation of [tau](/proteins/tau) and [Aβ](/proteins/amyloid-beta) precursor proteins
May contribute to accumulation of toxic aggregates
Parkinson's Disease
Loss of proteasome function in dopaminergic neurons
Impaired clearance of [α-synuclein](/proteins/alpha-synuclein)
Linked to LRRK2 and PARK genes
ALS
Proteasome dysfunction in motor neurons
Impaired degradation of [TDP-43](/mechanisms/tdp-43-proteinopathy) fragments
Related to sporadic and familial ALS
Huntington's Disease
Critical for degrading polyglutamine-expanded [huntingtin](/proteins/huntingtin)
Proteasome impairment contributes to toxicity
Therapeutic target for enhancing clearance
Therapeutic Implications
Current Approaches
Proteasome activators: Small molecules to enhance proteasome activity
The study of Psma2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.